RAB32 and bladder transitional cell carcinoma: The findings showcased the significance of RAB32 in multiple cancer types, including but not limited to bladder urothelial carcinoma (BLCA), acute myeloid leukemia (LAML), LGG, and pancreatic adenocarcinoma (PAAD) (Figure 1B).